News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Joins Hunt for Dengue Fever Drug in Tie-Up With Academia


8/30/2013 8:40:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson is joining the hunt for drugs to treat dengue fever - the world's fastest-spreading tropical disease - by linking with academic researchers in Belgium and the Wellcome Trust medical charity. There is currently no drug treatment or vaccine for the mosquito-borne viral disease, which is also called "breakbone fever" because of the severe pain it can cause. The tie-up between J&J's Janssen unit and researchers at the University of Leuven, who have received backing from Wellcome, will build on the discovery of a series of chemical compounds that are highly potent in preventing the replication of dengue virus.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Huffington Post
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES